Acute Myeloid Leukemia
Acute myeloid leukemia risk-adapted therapy discussed
Published in Cancer Weekly, August 22nd, 2006
"Genetic and molecular techniques have provided increasing insights into the biology of AML. These investigations showed that AML is not a homogeneous disease but a heterogeneous group of biologically different subentities," investigators in Germany reported.
"These subentities are currently primarily defined by cytogenetics and molecular markers. They differ substantially in response to therapy and long-term outcome and hence allow different risk groups of patients to be defined," explained W. Hiddemann and colleagues, University of Munich.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-08-22)
More Articles from Cancer Weekly
- Melanoma
Melanoma tumor growth and metastasis inhibited by GPR56 - Pancreatic Cancer
Pancreatic cancer apoptosis induced by SK-7041, a new histone deacetylase inhibitor - Prostate Cancer
Prostate cancer susceptibility linked to genetic polymorphisms in cytochrome P450 1A1 and 2E1 genes - Rectal Cancer
Risk of subsequent rectal cancer not heightened by prostatic irradiation - Anal Cancer
Anal carcinoma evaluated by FDG-PET/CT - Angiology
Guanine nucleotide exchange factors link EphA receptor to angiogenesis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
